Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Therapeutic Advances in Medical Oncology|May 25, 2026
Real-world comparative effectiveness of apalutamide versus enzalutamide for prostate-specific antigen response in metastatic castration-sensitive prostate cancerMehmet A Bilen, Benjamin H Lowentritt, Sabree Burbage, et al.Frontiers in Oncology|October 13, 2025
Time and cost burden associated with docetaxel in patients with metastatic castration-sensitive prostate cancer initiating an androgen receptor pathway inhibitor-based regimenDaniel Sentana-Lledo, Arjun Gupta, Carmine Rossi, et al.Advances in Therapy|June 17, 2025
Comparison of Real-World Outcomes between Patients with BRCA1/2-Positive and Homologous Recombination Repair-Negative Metastatic Castration-Sensitive Prostate CancerMehmet A Bilen, Sabree Burbage, Carmine Rossi, et al.Journal of Medical Economics|July 15, 2025
Healthcare resource utilization and costs among patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or enzalutamide in the United States (2019-2023)Mehmet A Bilen, Benjamin Lowentritt, Sabree Burbage, et al.Urology|January 31, 2026
Homologous recombination repair mutations, next-generation sequencing testing, and treatment progression by race among patients with metastatic castration-sensitive prostate cancerMehmet A Bilen, Neal Shore, Sabree Burbage, et al.Pageof 2